Should we use angiotensin II infusion in COVID-19-associated vasoplegic shock?

Karim Bendjelid

Published in: Critical care (London, England) (2020)

Keyphrases

angiotensin ii
coronavirus disease
sars cov
angiotensin converting enzyme
vascular smooth muscle cells
low dose
respiratory syndrome coronavirus